Laura Sutcliffe

Stock Analyst at UBS

(1.52)
# 3,293
Out of 4,884 analysts
6
Total ratings
66.67%
Success rate
-2.95%
Average return

Stocks Rated by Laura Sutcliffe

ResMed
Apr 24, 2025
Maintains: Buy
Price Target: $290$285
Current: $256.96
Upside: +10.91%
Telix Pharmaceuticals
Jan 27, 2025
Maintains: Buy
Price Target: $21$22
Current: $16.07
Upside: +36.90%
argenx SE
Jun 18, 2021
Initiates: Buy
Price Target: $390
Current: $543.48
Upside: -28.24%
Galapagos NV
Dec 20, 2019
Downgrades: Neutral
Price Target: n/a
Current: $28.83
Upside: -